Cardiff University-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Cardiff University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011826
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cardiff University is an educational institute that provides educational and research services. The institute offers services such as undergraduate courses, post graduate courses, international courses, accommodations, and libraries, among others. It conducts research in the areas of engineering and physical sciences, bio-medical and life sciences, and arts, humanities, and social sciences. Cardiff University offers courses in various disciplines including accounting, history, language, archaeology, architecture, astrophysics, banking and finance, biology, bio-medical science, biotechnology, business management, chemistry, civil engineering, computer science, criminology, dentistry, ecology, environment, geology, and others. The institute operates in Cardiff and Wales, the UK. Cardiff University is headquartered in Cardiff, the UK.

Cardiff University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cardiff University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cardiff University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cardiff University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cardiff University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Cardiff University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Cardiff University, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Diamyd Medical Enters into Partnership with Cardiff University 10
Licensing Agreements 11
Tiziana Life Sciences Enters into Licensing Agreement with Cardiff University 11
Cancer Research Technology, Cardiff University, And Institute of Cancer Research Extend Licensing Agreement With Merck Serono 12
Cardiff University – Key Competitors 14
Cardiff University – Key Employees 15
Cardiff University – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 18
Government and Public Interest 18
Nov 17, 2017: Improved method of engineering T-cells to attack cancer 18
Aug 31, 2016: Potential New Treatment for Cocaine Addiction 19
Jul 07, 2016: Grant funding received to explore Midatech’s gold nanoparticle technology in immunotherapy 20
Jul 07, 2016: Midatech Pharma: Grant funding received to explore Midatech’s gold nanoparticle technology in immunotherapy 21
May 05, 2016: Drug combination could help reduce risk of death in type 2 diabetes 22
Jan 13, 2016: Upgrading the immune system : Cardiff University 23
Jan 06, 2016: In a step toward personalized drug testing, researchers coax human stem cells to form complex tissues 24
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Cardiff University, Pharmaceuticals & Healthcare, Key Facts 2
Cardiff University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cardiff University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cardiff University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cardiff University, Deals By Therapy Area, 2011 to YTD 2017 8
Cardiff University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Diamyd Medical Enters into Partnership with Cardiff University 10
Tiziana Life Sciences Enters into Licensing Agreement with Cardiff University 11
Cancer Research Technology, Cardiff University, And Institute of Cancer Research Extend Licensing Agreement With Merck Serono 12
Cardiff University, Key Competitors 14
Cardiff University, Key Employees 15
Cardiff University, Other Locations 16
Cardiff University, Subsidiaries 17

★海外企業調査レポート[Cardiff University-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • LV=:企業の戦略・SWOT・財務分析
    SummaryLV= - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - Detailed …
  • Curtiss-Wright Corporation (CW):企業のM&A・提携動向(石油・ガス分野)
    Summary Curtiss-Wright Corporation (Curtiss-Wright) designs and manufactures highly engineered, technologically advanced products and services. The company provides products and services in the areas of motion control, flow control and electro mechanical treatment. The company’s products portfolio i …
  • Biman Bangladesh Airlines Ltd.:企業の戦略・SWOT・財務分析
    SummaryBiman Bangladesh Airlines Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compa …
  • Constellation Energy Partners LLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Constellation Energy Partners L …
  • EnXnet, Inc. (EXNT):企業概要、財務及び戦略的SWOT分析
    Summary EnXnet, Inc. (EnXnet) is a business and technology development company. The company develops and markets technologies and business strategies, practices and management. It offers products such as EPEC Unit, Tac Unit, ThinDisc, MoxyCard, OneDisc or VDPlus, EnXcase, assive Resonant Reflector, …
  • INVISTA S.a. r. l.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' INVISTA S.a. r. l. Mergers and …
  • Heliocentris Fuel Cells AG (H2FA):企業概要、財務及び戦略的SWOT分析
    Summary Heliocentris Fuel Cells AG (Heliocentris) is an energy management solution provider. The company develops, supplies and operates energy efficiency solutions and autonomous energy systems for customers in industry, science and education sectors. It provides services in information and communi …
  • We Energies:企業のM&A・提携動向(発電分野)
    Summary We Energies (WE), a subsidiary of WEC Energy Group, Inc., is a power company that offers electricity services. The company provides electricity generation and distribution services; generation, distribution and selling of electricity and steam. It generates electricity from coal, natural gas …
  • Dominion Resources, Inc. (D):企業のM&A・提携動向(石油・ガス分野)
    Summary Dominion Resources, Inc. (Dominion) is a leading producer and transporter of energy. It conducts the generation, transmission and distribution of electricity; transmission, distribution, storage and processing of gas; and LNG import and storage activities. The company generates electricity t …
  • BlueScope Steel Limited:企業のM&A・提携・投資分析
    BlueScope Steel Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BlueScope Steel Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Syneron Medical, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Syneron Medical, Ltd. Mergers a …
  • Oasis Petroleum Inc. (OAS):企業のM&A・提携動向(石油・ガス分野)
    Summary Oasis Petroleum Inc. (Oasis Petroleum) is an independent exploration and production company. It focuses on the acquisition and development of unconventional oil and natural gas resources. The company operates in the Williston Basin in North Dakota and Montana, which consists of project areas …
  • Elizabeth Arden, Inc.:企業の戦略・SWOT・財務分析
    SummaryElizabeth Arden, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key F …
  • Peter MacCallum Cancer Centre(製薬・医療分野):企業M&A動向
    Summary Peter MacCallum Cancer Centre (Peter Mac) is a health care service provider. The centre provides treatment for cancer, research and education. It provides patient care through specialist clinics based on tumor streams. The centre also offers surgical, medical, radiation, outpatient and inpat …
  • Banco Popular Espanol, S.A.:企業の戦略・SWOT・財務分析
    SummaryBanco Popular Espanol, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • ONStor, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' ONStor, Inc. Mergers and Acquis …
  • Cremer SA (CREM3):企業財務及び戦略的SWOT分析
    Summary Cremer SA (Cremer) is a pharmaceutical company that offers first aid, and surgery products. The company manufactures and sells healthcare products and adhesives which include hospital products, retail, industrial, dental products, export and diagnostic products. Its hospital products compris …
  • Alecta Pensionsforsakring Omsesidigt:企業の戦略的SWOT分析
    Alecta Pensionsforsakring Omsesidigt - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Roularta Media Group NV (ROU):企業概要、財務及び戦略的SWOT分析
    Summary Roularta Media Group NV (RMG) is an international multimedia company. The company’s national services include audiovisual, events, seminars and expositions, free regional sheets, internet, journals, line extensions, magazines, mobile, newsletters, production, services and yearbooks. Its inte …
  • Asia Polymer Corporation (1308):企業の財務及び戦略的SWOT分析
    Summary Asia Polymer Corporation (APC) is a resins manufacturing company that manufactures low density polyethylene (LDPE) resins and ethylene-vinyl acetate copolymer (EVA) resins. The company offers LDPE resins for use in medium duty films, frozen food packaging, liner bags, extruded tubes, general …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆